Both GD patients and healthy heterozygous carriers are at increased risk for PD [52]. About 10% of GBA mutation carriers will develop PD and studies suggest that penetrance is age dependent [53]. As in LRRK2, there is incomplete penetrance of PD among carriers and a wide range of penetrance estimates. This evidence concerns the gene LRRK2 and Parkinson disease.